ID MRTFB_HUMAN Reviewed; 1088 AA. AC Q9ULH7; A6ND53; B4DGT8; Q68CT1; Q6UB16; Q86WW2; Q8N226; DT 27-JUN-2003, integrated into UniProtKB/Swiss-Prot. DT 27-JUN-2003, sequence version 3. DT 27-MAR-2024, entry version 186. DE RecName: Full=Myocardin-related transcription factor B {ECO:0000305}; DE Short=MRTF-B {ECO:0000305}; DE AltName: Full=MKL/myocardin-like protein 2; DE AltName: Full=Megakaryoblastic leukemia 2 {ECO:0000303|PubMed:14565952}; GN Name=MRTFB {ECO:0000312|HGNC:HGNC:29819}; GN Synonyms=KIAA1243, MKL2 {ECO:0000303|PubMed:14565952}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), FUNCTION, TISSUE SPECIFICITY, AND RP INTERACTION WITH MRTFA AND SRF. RC TISSUE=Cervix carcinoma; RX PubMed=14565952; DOI=10.1074/jbc.m305679200; RA Selvaraj A., Prywes R.; RT "Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum RT response factor, is required for skeletal myogenic differentiation."; RL J. Biol. Chem. 278:41977-41987(2003). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 5). RC TISSUE=Brain, and Thymus; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15616553; DOI=10.1038/nature03187; RA Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G., RA Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E., RA Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M., RA Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C., RA Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M., RA Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M., RA Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D., RA Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., RA Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., RA Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., RA Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., RA Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J., RA Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D., RA Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S., RA Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A., RA Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M., RA Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H., RA Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A., RA Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J., RA DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J., RA Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., RA Myers R.M., Rubin E.M., Pennacchio L.A.; RT "The sequence and analysis of duplication-rich human chromosome 16."; RL Nature 432:988-994(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 5). RC TISSUE=Brain, Medulla oblongata, and Testis; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 261-1088 (ISOFORM 1). RC TISSUE=Brain; RX PubMed=10574462; DOI=10.1093/dnares/6.5.337; RA Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.; RT "Prediction of the coding sequences of unidentified human genes. XV. The RT complete sequences of 100 new cDNA clones from brain which code for large RT proteins in vitro."; RL DNA Res. 6:337-345(1999). RN [7] RP SEQUENCE REVISION. RX PubMed=12168954; DOI=10.1093/dnares/9.3.99; RA Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.; RT "Construction of expression-ready cDNA clones for KIAA genes: manual RT curation of 330 KIAA cDNA clones."; RL DNA Res. 9:99-106(2002). RN [8] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 415-1088 (ISOFORM 1). RC TISSUE=Amygdala; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [9] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66; THR-367; THR-370 AND RP SER-921, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [10] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Leukemic T-cell; RX PubMed=19690332; DOI=10.1126/scisignal.2000007; RA Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., RA Rodionov V., Han D.K.; RT "Quantitative phosphoproteomic analysis of T cell receptor signaling RT reveals system-wide modulation of protein-protein interactions."; RL Sci. Signal. 2:RA46-RA46(2009). RN [11] RP CHROMOSOMAL TRANSLOCATION WITH ZFTA. RX PubMed=20607705; DOI=10.1002/gcc.20788; RA Huang D., Sumegi J., Dal Cin P., Reith J.D., Yasuda T., Nelson M., RA Muirhead D., Bridge J.A.; RT "C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in RT chondroid lipoma."; RL Genes Chromosomes Cancer 49:810-818(2010). RN [12] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-541, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=20068231; DOI=10.1126/scisignal.2000475; RA Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., RA Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.; RT "Quantitative phosphoproteomics reveals widespread full phosphorylation RT site occupancy during mitosis."; RL Sci. Signal. 3:RA3-RA3(2010). RN [13] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [14] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66; SER-543 AND SER-921, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma, and Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [15] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22 (ISOFORMS 4 AND 5), AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [16] RP SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-628, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=25114211; DOI=10.1073/pnas.1413825111; RA Impens F., Radoshevich L., Cossart P., Ribet D.; RT "Mapping of SUMO sites and analysis of SUMOylation changes induced by RT external stimuli."; RL Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014). RN [17] RP VARIANT GLY-390. RX PubMed=21248752; DOI=10.1038/nature09639; RA Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P., Davies H., RA Jones D., Lin M.L., Teague J., Bignell G., Butler A., Cho J., RA Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C., Jia M., RA Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A., Mudie L., RA Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S., Kahnoski R.J., RA Anema J., Tuveson D.A., Perez-Mancera P.A., Mustonen V., Fischer A., RA Adams D.J., Rust A., Chan-On W., Subimerb C., Dykema K., Furge K., RA Campbell P.J., Teh B.T., Stratton M.R., Futreal P.A.; RT "Exome sequencing identifies frequent mutation of the SWI/SNF complex gene RT PBRM1 in renal carcinoma."; RL Nature 469:539-542(2011). CC -!- FUNCTION: Acts as a transcriptional coactivator of serum response CC factor (SRF). Required for skeletal myogenic differentiation. CC {ECO:0000269|PubMed:14565952}. CC -!- SUBUNIT: Interacts with MRTFA and SRF. {ECO:0000269|PubMed:14565952}. CC -!- INTERACTION: CC Q9ULH7; P11831: SRF; NbExp=3; IntAct=EBI-493007, EBI-493034; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=5; CC Name=1; CC IsoId=Q9ULH7-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9ULH7-2; Sequence=VSP_007653, VSP_007654, VSP_007655; CC Name=3; CC IsoId=Q9ULH7-3; Sequence=VSP_007656, VSP_007657; CC Name=4; CC IsoId=Q9ULH7-4; Sequence=VSP_013355, VSP_013356; CC Name=5; CC IsoId=Q9ULH7-5; Sequence=VSP_013355; CC -!- DOMAIN: The N-terminal region is required for nuclear localization and CC the C-terminal region mediates transcriptional activity. {ECO:0000250}. CC -!- PTM: O-glycosylated. {ECO:0000250}. CC -!- DISEASE: Note=A chromosomal aberration involving ZFTA is found in 3 CC chondroid lipomas. Translocation t(11;16)(q13;p13) with ZFTA produces a CC ZFTA-MRTFB fusion protein (PubMed:20607705). CC {ECO:0000269|PubMed:20607705}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY374297; AAQ82435.1; -; mRNA. DR EMBL; AK093577; BAC04200.1; -; mRNA. DR EMBL; AK294765; BAG57899.1; -; mRNA. DR EMBL; AC012626; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC040173; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC130650; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471112; EAW85112.1; -; Genomic_DNA. DR EMBL; BC047761; AAH47761.1; -; mRNA. DR EMBL; BC136260; AAI36261.1; -; mRNA. DR EMBL; BC171750; AAI71750.1; -; mRNA. DR EMBL; AB033069; BAA86557.2; -; mRNA. DR EMBL; CR749797; CAH18657.1; -; mRNA. DR CCDS; CCDS32391.1; -. [Q9ULH7-4] DR CCDS; CCDS76823.1; -. [Q9ULH7-5] DR RefSeq; NP_001295071.1; NM_001308142.1. [Q9ULH7-5] DR RefSeq; NP_054767.3; NM_014048.4. [Q9ULH7-4] DR RefSeq; XP_005255509.1; XM_005255452.3. [Q9ULH7-5] DR RefSeq; XP_005255510.1; XM_005255453.4. DR RefSeq; XP_005255512.1; XM_005255455.3. DR RefSeq; XP_006720971.1; XM_006720908.3. DR RefSeq; XP_006720972.1; XM_006720909.3. [Q9ULH7-5] DR RefSeq; XP_006720977.1; XM_006720914.2. [Q9ULH7-4] DR RefSeq; XP_011520870.1; XM_011522568.2. [Q9ULH7-5] DR RefSeq; XP_016878990.1; XM_017023501.1. [Q9ULH7-5] DR RefSeq; XP_016878991.1; XM_017023502.1. [Q9ULH7-5] DR AlphaFoldDB; Q9ULH7; -. DR SMR; Q9ULH7; -. DR BioGRID; 121563; 54. DR ELM; Q9ULH7; -. DR IntAct; Q9ULH7; 20. DR MINT; Q9ULH7; -. DR STRING; 9606.ENSP00000459626; -. DR GlyCosmos; Q9ULH7; 1 site, 1 glycan. DR GlyGen; Q9ULH7; 5 sites, 1 O-linked glycan (5 sites). DR iPTMnet; Q9ULH7; -. DR MetOSite; Q9ULH7; -. DR PhosphoSitePlus; Q9ULH7; -. DR BioMuta; MKL2; -. DR DMDM; 32363203; -. DR EPD; Q9ULH7; -. DR jPOST; Q9ULH7; -. DR MassIVE; Q9ULH7; -. DR MaxQB; Q9ULH7; -. DR PaxDb; 9606-ENSP00000339086; -. DR PeptideAtlas; Q9ULH7; -. DR ProteomicsDB; 4158; -. DR ProteomicsDB; 85028; -. [Q9ULH7-1] DR ProteomicsDB; 85029; -. [Q9ULH7-2] DR ProteomicsDB; 85030; -. [Q9ULH7-3] DR ProteomicsDB; 85031; -. [Q9ULH7-4] DR Pumba; Q9ULH7; -. DR Antibodypedia; 1832; 138 antibodies from 25 providers. DR DNASU; 57496; -. DR Ensembl; ENST00000318282.9; ENSP00000339086.4; ENSG00000186260.17. [Q9ULH7-4] DR Ensembl; ENST00000571589.6; ENSP00000459626.2; ENSG00000186260.17. [Q9ULH7-5] DR Ensembl; ENST00000573051.1; ENSP00000460589.1; ENSG00000186260.17. [Q9ULH7-2] DR Ensembl; ENST00000574045.5; ENSP00000459205.1; ENSG00000186260.17. [Q9ULH7-4] DR GeneID; 57496; -. DR KEGG; hsa:57496; -. DR MANE-Select; ENST00000571589.6; ENSP00000459626.2; NM_001308142.2; NP_001295071.1. [Q9ULH7-5] DR UCSC; uc002dcg.4; human. [Q9ULH7-1] DR AGR; HGNC:29819; -. DR CTD; 57496; -. DR DisGeNET; 57496; -. DR GeneCards; MRTFB; -. DR HGNC; HGNC:29819; MRTFB. DR HPA; ENSG00000186260; Low tissue specificity. DR MIM; 609463; gene. DR neXtProt; NX_Q9ULH7; -. DR OpenTargets; ENSG00000186260; -. DR PharmGKB; PA134981329; -. DR VEuPathDB; HostDB:ENSG00000186260; -. DR eggNOG; ENOG502QU1Z; Eukaryota. DR GeneTree; ENSGT00950000182979; -. DR HOGENOM; CLU_007042_0_0_1; -. DR InParanoid; Q9ULH7; -. DR OMA; TMCNNTA; -. DR OrthoDB; 2997330at2759; -. DR PhylomeDB; Q9ULH7; -. DR TreeFam; TF326024; -. DR PathwayCommons; Q9ULH7; -. DR SignaLink; Q9ULH7; -. DR SIGNOR; Q9ULH7; -. DR BioGRID-ORCS; 57496; 7 hits in 1161 CRISPR screens. DR ChiTaRS; MKL2; human. DR GeneWiki; MKL2; -. DR GenomeRNAi; 57496; -. DR Pharos; Q9ULH7; Tbio. DR PRO; PR:Q9ULH7; -. DR Proteomes; UP000005640; Chromosome 16. DR RNAct; Q9ULH7; Protein. DR Bgee; ENSG00000186260; Expressed in Brodmann (1909) area 23 and 209 other cell types or tissues. DR ExpressionAtlas; Q9ULH7; baseline and differential. DR GO; GO:0005634; C:nucleus; IBA:GO_Central. DR GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL. DR GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB. DR GO; GO:0007517; P:muscle organ development; IEA:UniProtKB-KW. DR GO; GO:1902895; P:positive regulation of miRNA transcription; IGI:ARUK-UCL. DR GO; GO:0045844; P:positive regulation of striated muscle tissue development; IDA:UniProtKB. DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB. DR GO; GO:0051145; P:smooth muscle cell differentiation; IBA:GO_Central. DR Gene3D; 6.10.140.2040; -; 1. DR Gene3D; 6.10.150.10; -; 1. DR Gene3D; 1.10.720.30; SAP domain; 1. DR InterPro; IPR043451; Myocardin-like. DR InterPro; IPR004018; RPEL_repeat. DR InterPro; IPR003034; SAP_dom. DR InterPro; IPR036361; SAP_dom_sf. DR PANTHER; PTHR22793:SF5; MYOCARDIN-RELATED TRANSCRIPTION FACTOR B; 1. DR PANTHER; PTHR22793; MYOCARDIN-RELATED TRANSCRIPTION FACTOR-RELATED; 1. DR Pfam; PF02755; RPEL; 2. DR Pfam; PF02037; SAP; 1. DR SMART; SM00707; RPEL; 3. DR SMART; SM00513; SAP; 1. DR SUPFAM; SSF68906; SAP domain; 1. DR PROSITE; PS51073; RPEL; 3. DR PROSITE; PS50800; SAP; 1. DR Genevisible; Q9ULH7; HS. PE 1: Evidence at protein level; KW Activator; Alternative splicing; Chromosomal rearrangement; Coiled coil; KW Developmental protein; Differentiation; Glycoprotein; Isopeptide bond; KW Myogenesis; Nucleus; Phosphoprotein; Reference proteome; Repeat; KW Transcription; Transcription regulation; Ubl conjugation. FT CHAIN 1..1088 FT /note="Myocardin-related transcription factor B" FT /id="PRO_0000126628" FT REPEAT 40..65 FT /note="RPEL 1" FT REPEAT 84..109 FT /note="RPEL 2" FT REPEAT 128..153 FT /note="RPEL 3" FT DOMAIN 389..423 FT /note="SAP" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00186" FT REGION 165..310 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 349..389 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 472..508 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 528..553 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 563..591 FT /note="Required for interaction with itself and with MRTFA" FT REGION 595..655 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 829..886 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COILED 545..601 FT /evidence="ECO:0000255" FT COMPBIAS 177..224 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 235..249 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 273..293 FT /note="Basic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 294..310 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 351..382 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 601..621 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 631..645 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT SITE 394 FT /note="Breakpoint for translocation to form ZFTA-MRTFB FT fusion protein" FT MOD_RES 66 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:23186163" FT MOD_RES 367 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:18669648" FT MOD_RES 370 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:18669648" FT MOD_RES 541 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:20068231" FT MOD_RES 543 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 921 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:23186163" FT CROSSLNK 628 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO1)" FT /evidence="ECO:0007744|PubMed:25114211" FT VAR_SEQ 1..41 FT /note="MIDSSKKQQQGFPEILTAGDFEPLKEKECLEGSNQKSLKEV -> M (in FT isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_007653" FT VAR_SEQ 1..40 FT /note="MIDSSKKQQQGFPEILTAGDFEPLKEKECLEGSNQKSLKE -> MDHTGAID FT TEDEVGPLAHLAPSPQSEAVAHEFQELSLQSSQNLPPLNERKN (in isoform 4 FT and isoform 5)" FT /evidence="ECO:0000303|PubMed:14565952, FT ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334" FT /id="VSP_013355" FT VAR_SEQ 350..461 FT /note="PLNDKNSNSGNSALNNATPNTPRQNTSTPVRKPGPLPSSLDDLKVSELKTEL FT KLRGLPVSGTKPDLIERLKPYQEVNSSGLAAGGIVAVSSSAIVTSNPEVTVALPVTTLH FT N -> YGGAHAILNAGFSVVFMRNYKLPKVECCHLFVLSNDFHFFVIRAYHTVSEVHMV FT RVACIPFQFLSSKIGSEFLQVRNAFSQLFIQICLLLEHQNSTRCSEKSVSSIIPGINS FT (in isoform 3)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_007656" FT VAR_SEQ 350..418 FT /note="PLNDKNSNSGNSALNNATPNTPRQNTSTPVRKPGPLPSSLDDLKVSELKTEL FT KLRGLPVSGTKPDLIER -> AYHTVSEVHMVRVACIPFQFLSSKIGSEFLQVRNAFSQ FT LFIQICLLLEHQNSTRCSEKSVSSIIPGINS (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_007654" FT VAR_SEQ 419..1088 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_007655" FT VAR_SEQ 462..1088 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_007657" FT VAR_SEQ 689..738 FT /note="Missing (in isoform 4)" FT /evidence="ECO:0000303|PubMed:14565952" FT /id="VSP_013356" FT VARIANT 390 FT /note="D -> G (found in a renal cell carcinoma sample; FT somatic mutation)" FT /evidence="ECO:0000269|PubMed:21248752" FT /id="VAR_064732" FT CONFLICT 266 FT /note="K -> R (in Ref. 2; BAC04200)" FT /evidence="ECO:0000305" FT CONFLICT 350 FT /note="P -> A (in Ref. 1; AAQ82435)" FT /evidence="ECO:0000305" FT CONFLICT 592 FT /note="E -> G (in Ref. 8; CAH18657)" FT /evidence="ECO:0000305" FT CONFLICT 598 FT /note="Q -> R (in Ref. 1; AAQ82435)" FT /evidence="ECO:0000305" FT CONFLICT 629 FT /note="D -> G (in Ref. 1; AAQ82435)" FT /evidence="ECO:0000305" FT MOD_RES Q9ULH7-4:22 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:24275569" FT MOD_RES Q9ULH7-5:22 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:24275569" SQ SEQUENCE 1088 AA; 118127 MW; 0CA4A52A115C0C83 CRC64; MIDSSKKQQQ GFPEILTAGD FEPLKEKECL EGSNQKSLKE VLQLRLQQRR TREQLVDQGI MPPLKSPAAF HEQIKSLERA RTENFLKHKI RSRPDRSELV RMHILEETFA EPSLQATQMK LKRARLADDL NEKIAQRPGP MELVEKNILP VDSSVKEAII GVGKEDYPHT QGDFSFDEDS SDALSPDQPA SQESQGSAAS PSEPKVSESP SPVTTNTPAQ FASVSPTVPE FLKTPPTADQ PPPRPAAPVL PTNTVSSAKP GPALVKQSHP KNPNDKHRSK KCKDPKPRVK KLKYHQYIPP DQKGEKNEPQ MDSNYARLLQ QQQLFLQLQI LSQQKQHYNY QTILPAPFKP LNDKNSNSGN SALNNATPNT PRQNTSTPVR KPGPLPSSLD DLKVSELKTE LKLRGLPVSG TKPDLIERLK PYQEVNSSGL AAGGIVAVSS SAIVTSNPEV TVALPVTTLH NTVTSSVSTL KAELPPTGTS NATRVENVHS PLPISPSPSE QSSLSTDDTN MADTFTEIMT MMSPSQFLSS SPLRMTNNED SLSPTSSTLS NLELDAAEKD RKLQEKEKQI EELKRKLEQE QKLVEVLKMQ LEVEKRGQQQ RPLEAQPSAP GHSVKSDQKH GSLGSSIKDE ASLPDCSSSR QPIPVASHAV GQPVSTGGQT LVAKKAVVIK QEVPVGQAEQ QSVVSQFYVS SQGQPPPAVV AQPQALLTTQ TAQLLLPVSI QGSSVTSVQL PVGSLKLQTS PQAGMQTQPQ IATAAQIPTA ALASGLAPTV PQTQDTFPQH VLSQPQQVRK VFTNSASSNT VLPYQRHPAP AVQQPFINKA SNSVLQSRNA PLPSLQNGPN TPNKPSSPPP PQQFVVQHSL FGSPVAKTKD PPRYEEAIKQ TRSTQAPLPE ISNAHSQQMD DLFDILIKSG EISLPIKEEP SPISKMRPVT ASITTMPVNT VVSRPPPQVQ MAPPVSLEPM GSLSASLENQ LEAFLDGTLP SANEIPPLQS SSEDREPFSL IEDLQNDLLS HSGMLDHSHS PMETSETQFA AGTPCLSLDL SDSNLDNMEW LDITMPNSSS GLTPLSTTAP SMFSADFLDP QDLPLPWD //